A team at UCSF developed a multitask deep learning framework that can effectively predict Alzheimer’s disease diagnosis, cognitive scores, and future cognitive decline using only baseline MRI and ...

A new study suggests the APOE2 longevity gene may protect the brain from Alzheimer's by helping neurons repair DNA damage and resist cell aging.

ACADIA Pharmaceuticals (NASDAQ:ACAD) executives used an RBC Capital Markets investor session to outline the company’s clinical rationale for remlifanserin in Alzheimer’s disease psychosis, provide ...

“This will be a bigger and bigger concern as the population ages.” ...

Passage of the Alzheimer’s Screening and Prevention Act is one of several practical steps available to reduce rural health disparities.

Christopher Lock, MD, spoke with Healio about findings from the Evoke and Evoke+ trials presented at the 2026 American ...

Conventional wisdom suggests that voter angst over healthcare affordability will haunt the party in power this November. But ...

While there is currently no cure for Alzheimer's, a new study suggests eggs could help lower your risk of developing the ...

Japanese medical startup Sound Wave Innovation, which aims to cure Alzheimer’s disease with ultrasound therapy, has raised ...

New sites in New Jersey, New York, and Florida broaden geographic reach and increase access for patients participating in Phase 2 trial of troculeucel in moderate Alzheimer’s disease.

Risen Pharma, a clinical-stage biotech company focusing on the development and commercialization of high-need, patient-accessible therapeutics, today announced the initiation of a Phase ...